Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Roadblocks in Chagas disease care in endemic and nonendemic countries: Argentina, Colombia, Spain, and the United States. The NET-Heart project.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Corporate Authors:
      Neglected Tropical Diseases and other Infectious Diseases affecting the Heart (NET-Heart) project
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
      Chagas Disease/*epidemiology ; Chagas Disease/*psychology; Antiprotozoal Agents/therapeutic use ; Argentina/epidemiology ; Awareness ; Chagas Disease/drug therapy ; Chagas Disease/transmission ; Colombia/epidemiology ; Health Services Accessibility ; Humans ; Social Stigma ; Spain/epidemiology ; United States/epidemiology
    • Abstract:
      Competing Interests: The authors have declared that no competing interests exist.
      Background: Chagas disease (CD) is endemic in Latin America; however, its spread to nontropical areas has raised global interest in this condition. Barriers in access to early diagnosis and treatment of both acute and chronic infection and their complications have led to an increasing disease burden outside of Latin America. Our goal was to identify those barriers and to perform an additional analysis of them based on the Inter American Society of Cardiology (SIAC) and the World Heart Federation (WHF) Chagas Roadmap, at a country level in Argentina, Colombia, Spain, and the United States, which serve as representatives of endemic and nonendemic countries.
      Methodology and Principal Findings: This is a nonsystematic review of articles published in indexed journals from 1955 to 2021 and of gray literature (local health organizations guidelines, local policies, blogs, and media). We classified barriers to access care as (i) existing difficulties limiting healthcare access; (ii) lack of awareness about CD and its complications; (iii) poor transmission control (vectorial and nonvectorial); (iv) scarce availability of antitrypanosomal drugs; and (v) cultural beliefs and stigma. Region-specific barriers may limit the implementation of roadmaps and require the application of tailored strategies to improve access to appropriate care.
      Conclusions: Multiple barriers negatively impact the prognosis of CD. Identification of these roadblocks both nationally and globally is important to guide development of appropriate policies and public health programs to reduce the global burden of this disease.
    • References:
      Gates Open Res. 2019 Sep 17;3:1539. (PMID: 31781687)
      PLoS One. 2019 Jan 7;14(1):e0210156. (PMID: 30615644)
      PLoS Negl Trop Dis. 2021 Jan 7;15(1):e0008912. (PMID: 33412557)
      Transplant Rev (Orlando). 2011 Jul;25(3):91-101. (PMID: 21530219)
      Lancet. 2013 Apr 6;381(9873):1235-45. (PMID: 23541058)
      Am J Trop Med Hyg. 2014 Nov;91(5):915-9. (PMID: 25200261)
      Aten Primaria. 2015 May;47(5):308-17. (PMID: 25704793)
      Glob Heart. 2020 Oct 13;15(1):69. (PMID: 33150134)
      Circulation. 2018 Sep 18;138(12):e169-e209. (PMID: 30354432)
      PLoS Negl Trop Dis. 2020 Oct 1;14(10):e0008418. (PMID: 33001966)
      Glob Heart. 2020 Sep 01;15(1):60. (PMID: 32923353)
      PLoS One. 2020 Jul 14;15(7):e0235466. (PMID: 32663211)
      PLoS Negl Trop Dis. 2014 Apr 17;8(4):e2776. (PMID: 24743112)
      Acta Trop. 2010 Jul-Aug;115(1-2):22-7. (PMID: 19646412)
      Am J Trop Med Hyg. 2015 Jul;93(1):108-13. (PMID: 25986581)
      Lancet Glob Health. 2017 Apr;5(4):e439-e447. (PMID: 28256340)
      PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2410. (PMID: 24069473)
      Euro Surveill. 2011 Sep 15;16(37):. (PMID: 21944556)
      Curr Treat Options Infect Dis. 2018;10(3):373-388. (PMID: 30220883)
      HIV Clin Trials. 2011 Nov-Dec;12(6):287-98. (PMID: 22189148)
      Medicina (B Aires). 2019;79(2):81-89. (PMID: 31048272)
      Rev Panam Salud Publica. 2017 Dec 05;41:e153. (PMID: 31384272)
      Clin Microbiol Rev. 2011 Oct;24(4):655-81. (PMID: 21976603)
      Clin Infect Dis. 2021 May 4;72(9):e303-e310. (PMID: 32766826)
      Glob Heart. 2020 Mar 30;15(1):26. (PMID: 32489799)
      Rev Esp Cardiol. 2007 Mar;60(3):285-93. (PMID: 17394874)
      PLoS Negl Trop Dis. 2019 Sep 26;13(9):e0007447. (PMID: 31557155)
      Enferm Infecc Microbiol Clin. 2013 Oct;31(8):535-42. (PMID: 23374862)
      Am J Trop Med Hyg. 2020 Jul;103(1):437-444. (PMID: 32342845)
      Rev Panam Salud Publica. 2016 Jun;39(6):341-351. (PMID: 27706434)
      Gastroenterol Hepatol. 2010 Mar;33(3):191-200. (PMID: 19837482)
      Medicina (B Aires). 2021;81(4):675-676. (PMID: 34453823)
      Stroke. 2010 Feb;41(2):256-60. (PMID: 20044517)
    • Accession Number:
      0 (Antiprotozoal Agents)
    • Publication Date:
      Date Created: 20211230 Date Completed: 20220218 Latest Revision: 20220218
    • Publication Date:
      20250114
    • Accession Number:
      PMC8717966
    • Accession Number:
      10.1371/journal.pntd.0009954
    • Accession Number:
      34968402